Results 41 to 50 of about 38,562 (258)
Nitrates for the Management of Acute Heart Failure Syndromes, A Systematic Review [PDF]
, 2016 © The Author(s) 2016Intravenous nitrates are widely used in the management of acute heart failure syndrome (AHFS) yet with lack of robust evidence to support their use.
Farag, Mohamed +2 more
core +2 more sources
Рациональная фармакотерапия в кардиологии, 2020 Heart failure (HF) is a growing public health problem with an estimated prevalence of 38 million patients worldwide. Congestion and formation of edema – are typical symptoms of heart failure. Diuretics are the mainstay of therapy in heart failure and are
N. M. Gafurova +2 more
doaj +1 more source
Loop Diuretics in Clinical Practice [PDF]
Electrolytes & Blood Pressure, 2015 Diuretics are commonly used to control edema across various clinical fields. Diuretics inhibit sodium reabsorption in specific renal tubules, resulting in increased urinary sodium and water excretion. Loop diuretics are the most potent diuretics. In this article, we review five important aspects of loop diuretics, in particular furosemide, which must ...
Oh, Se Won, Han, Sang Youb
openaire +2 more sources
The effect of cardiac resynchronization on morbidity and mortality in heart failure [PDF]
, 2005 Background: Cardiac resynchronization reduces symptoms and improves left ventricular function in many patients with heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony.
Cleland, John G.F. +6 more
core +1 more source
Sequential Blockade with Loop Diuretics and Acetazolamide: A Novel Strategy in Acute Heart Failure
Journal of the Indian Academy of GeriatricsAcute decompensated heart failure (HF) is the most common form of acute HF (AHF) and presents with systemic congestion due to left ventricular dysfunction with sodium and water retention.
Nitin R. Gaikwad +2 more
doaj +1 more source
Studia Universitatis Babes-Bolyai Chemia, 2017 It is well known that long term administration of high dose loop diuretics in patients with heart failure, may in some cases aggravate the cardiac failure symptoms. Part of this effect may be due to thiamine depletion secondary to diuretics use. The aim
Dana-Adriana ILUȚIU-VARVARA +2 more
doaj +1 more source
Kidney DiseasesIntroduction: VERTIS CV was a placebo-controlled cardiovascular (CV) outcome trial evaluating the sodium-glucose cotransporter 2 inhibitor ertugliflozin in patients with type 2 diabetes and established atherosclerotic CV disease.
David Z.I. Cherney +10 more
doaj +1 more source
Relationship between antihypertensive medications and cognitive impairment: Part I. review of human studies and clinical trials [PDF]
, 2016 Purpose of review: There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer’s disease; however, associations between antihypertensive medications (AHMs) and dementia risk ...
Anstey, KJ +5 more
core +2 more sources
Pharmacogenetics of loop diuretics
Clinical Pharmacology & Therapeutics, 2004 Objective Genetic variability in pharmacokinetics and pharmacodynamics of diuretics is incompletely studied. We compared the extent of variability in different loop diuretics and determined to what extent this is influenced by polymorphisms in candidate genes. Methods Single oral doses of bumetanide 2 mg, furosemide 80 mg and torasemide 10
Vormfelde, Stefan Viktor +6 more
openaire +2 more sources
Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure. [PDF]
, 2014 OBJECTIVES: The GUIDE-IT (Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure) study is designed to determine the safety, efficacy, and cost-effectiveness of a strategy of adjusting therapy with the goal of achieving and
Adams, Kirkwood F. +15 more
core +3 more sources